Gefitinib vs Lithium Carbonate

Gefitinib vs Lithium Carbonate: Overview

This comparison examines the pharmacological differences between Gefitinib and Lithium Carbonate.

Mechanism of Action

Gefitinib: Selective reversible inhibitor of EGFR tyrosine kinase.

Lithium Carbonate: Modulates intracellular signaling via inositol and GSK-3 inhibition.

Pharmacokinetics

Half-life: Gefitinib — 48 hours; Lithium Carbonate — 18-36 hours.

Chemical Properties

Molecular Formula: Gefitinib — C22H24ClFN4O3; Lithium Carbonate — Li2CO3.

Molecular Weight: Gefitinib — 446.9000 g/mol; Lithium Carbonate — 73.8910 g/mol.

Type: Gefitinib — Small molecule; Lithium Carbonate — Small molecule.